4.47

0.22% 0.010

Silo Pharma Inc (SILO)

Overview News Price History Financials Discussions Forecast Stock Split

Silo Pharma Inc stock is traded at $4.47, with a volume of 32,208. It is up +0.22% in the last 24 hours and down -28.14% over the past month. SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's portfolio includes programs such as SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer's disease and multiple sclerosis. The company's product pipelines include: SPC-14, SPC-15, SP-26, and SPU-16. The company operates as a single operating segment as a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical need.

Previous Close:

$4.46

Open:

$4.43

24h Volume:

32,208

Relative Volume:

0.21

Market Cap:

$5.04M

Revenue:

$72,100

Net Income/Loss:

$-4.84M

P/E Ratio:

-0.5995

EPS:

-7.4566

Net Cash Flow:

$-3.84M

1W Performance:

-8.02%

1M Performance:

-28.14%

6M Performance:

-19.74%

1Y Performance:

-54.88%

1-Day Range:

$4.2018

$4.55

1-Week Range:

$4.2018

$4.85

52-Week Range:

$3.315

$15.15

Silo Pharma Inc Stock (SILO) Company Profile

Name

Silo Pharma Inc

Sector

Healthcare (1071)

Industry

Biotechnology (598)

Phone

(718) 400-9031

Address

677 N. WASHINGTON BLVD, SARASOTA

Employee

Twitter

Next Earnings Date

2026-08-12

Latest SEC Filings

SILO's Discussions on Twitter

Compare SILO vs PSNYW, GOODO, SHMD, DWLD, QQQE

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SILO SILO PHARMA INC	1.71	17.96M	0	0	0	0.00
PSNYW Polestar Automotive Holding Uk	2.79	404.28M	2.07B	-1.42B	-1.37B	-0.6765
GOODO Gladstone Commercial Corporation	20.39	372.90M	0	0	0	0.00
SHMD Schmid Group N V	4.115	270.26M	52.15M	-21.46M	0	-0.4675
DWLD Davis Select Worldwide ETF	46.71	0	0	0	0	0.00
QQQE Direxion NASDAQ-100 Equal Weigh	115.41	0	0	0	0	0.00

Silo Pharma Inc Stock (SILO) Latest News

Jul 24, 2026

Silo Pharma Selling Shareholders Offer On Resale Basis 1.9 Million Shares Of Silo Pharma Common StockSEC Filing - TradingView

Jul 24, 2026

Form S-3 Silo Pharma Inc For: 24 July By Investing.com - Investing.com Canada

Jul 24, 2026

Jul 21, 2026

Silo Pharma Advances AI Agent Platform Toward Commercial Launch And Progresses Lead PTSD Drug Program SPC-15 - marketscreener.com

Jul 21, 2026

Silo Pharma plans AI platform launch, advances PTSD drug program By Investing.com - Investing.com Canada

Jul 21, 2026

Silo Pharma expects its PTSD nasal-spray study to finish in 60 days - Stock Titan

Jul 21, 2026

Jul 20, 2026

Silo Pharma raises $4 million in private placement By Investing.com - Investing.com Nigeria

Jul 20, 2026

Jul 16, 2026

Silo Pharma unit eyes faster AI agent development through AMD partnership - MSN

Jul 16, 2026

Jul 15, 2026

Silo Pharma (SILO) completes $4,000,015 private exempt securities sale - Stock Titan

Jul 15, 2026

Silo Pharma Advances AI Integration and PTSD Treatment Development - sekbernews.id

Jul 15, 2026

Is Silo Pharma, Inc. (SILO) Stock an AI Opportunity After NVIDIA Partnership Boosts QwikAgents Platform? - Yahoo Finance

Jul 15, 2026

Jul 14, 2026

Silo Pharma Subsidiary QwikAgents Joins AMD AI Developer Program to Accelerate AI Agent Platform - citybuzz -

Jul 14, 2026

Silo Pharma (SILO) Shares Drop 4.92% Following QwikAgents' Entry into AMD AI Developer Program - Blockonomi

Jul 14, 2026

Why Is Silo Pharma Stock Volatile Today?SILO Pharma (NASDAQ:SILO) - Benzinga

Jul 14, 2026